Related Experiment Video
Updated: Jul 12, 2026

Using High Content Imaging to Quantify Target Engagement in Adherent Cells
Published on: November 29, 2018
A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery
Isabel Martín Caballero1, Stina Lundgren1
1Pelago Bioscience AB, 17165 Solna, Sweden.
Abstract:
A decade has passed since the cellular thermal shift assay (CETSA) was introduced to the drug discovery community. Over the years, the method has guided numerous projects by providing insights about, for example, target engagement, lead generation, target identification, lead optimization, and preclinical profiling. With this Microperspective, we intend to highlight recently published applications of CETSA and how the data generated can enable efficient decision-making and prioritization throughout the drug discovery and development value chain.

